Summary.-Techniques are described for hapten attachment to the cell membranes of mouse tumour cells. Dinitrophenylation and tyrosylation could be achieved without substantial loss of viability as measured by dye exclusion. In addition hapten coated tumour cells were capable of initiating new tumour formation in syngeneic hosts. Pre-immunization of recipient mice with hapten coated tumour cells did not increase their resistance to tumour formation upon subsequent challenge with graded doses of untreated tumour cells.
REJECTION of tumours is due in part to the ability of the host to react to tumour-specific transplantation antigens (TSTA) present in the tumour cell membrane. The immunogenicity of many antigens depends upon the co-operative interaction of two immunologically competent cells with the antigen, each at the site of a different antigenic determinant on the antigen molecule, commonly referred to as " carrier " and " haptenic " sites. If TSTA differ from host cell surface antigens by only a single, or a restricted number of antigenic determinants, cellular synergy, which has been demonstrated for cellular immunity as well as for humoral antibody response, may not be possible. Under such circumstances, introduction of other antigenic determinants into the tumour cell membrane may enhance the ability of the host to mount an immune response against the tumour cell. A variety of experimental observations suggest that such a mechanism may indeed result in increased resistance to in vivo tumour cell growth. The theoretical framework for the role of cell co-operation in tumour immunity, and speculations on manipulations that might enhance tumour rejection have been presented by Mitchison (1970) .
The present investigation was undertaken to study whether or not the immunogenicity of a murine leukaemia cell could be enhanced by the exogenous introduction of dinitrophenyl (DNP) or tyrosyl (TYR) groups on to the tumour cell membrane. In view of the ability of excess hapten groups to interfere with immune responses to certain tumour cells (Wolf, Parry and Barfoot, 1970) , particular attention was paid to the details of the procedures for hapten attachment. Tumour cells were reacted with hapten so that viability as measured by trypan blue exclusion was not affected and a substantial proportion of cells were still able to initiate tumour formation.
MATERIALS AND METHODS

Mice
CBA male mice between the ages of 10 and 16 weeks were used in all studies.
Tumour ce1ls
Gross passage A virus-induced leukaemia was initiated in newborn male CBA mice, and the leukaemic cells were adapted to growth as solid tumours in the subcutaneous tissue of adult male CBA mice. Cells derived from the 3-5 subcutaneous passage of the tumour were used in the experiments to be described. * Present address: Weizmann Institute of Science, Rehovot, Israel.
To obtain tumour cell suspensions, mice bearing subcutaneous tumour masses were killed by cervical dislocation, and the tumour masses were dissected free of surrounding tissue. Single cell suspensions were prepared by mincing the tumour tissue with stainless steel scissors, gently pressing the minced tissue through nylon mesh, and filtering the resultant cell suspension through ethanol washed (and dried) cotton wool. This removed cell clumps and tissue fragments as well as many of the non-viable cells as measured by trypan blue dye exclusion. All the above procedures were performed in cold (0-4' C) Gey's solution, pH 7-4.
Dinitrophenylation of tumour cells
Twenty-five ,ul of dinitrofluorobenzene (DNFB) were dissolved in 0 5 ml dimethylsulfoxide (DMSO 
Assessment of number of T YR sites on tumour cells
The polytyrosyl cells were tested for agglutination by rabbit antiserum against poly-L-tyrosyl gelatin, prepared as described by Sela and Arnon (1960) . This antiserum contained about 0 5 mg antibody directed against poly-L-tyrosyl determinants. The reaction was performed by mixing 0-2 ml of serial dilutions of the antiserum with 0-1 ml of cell suspension (1 x 107/ml), followed by incubation for one hour at 37°C and overnight at 40C. Untreated tumour cells were used as controls. Normal rabbit serum did not cause agglutination.
Antigenic structure of tyrosylated cells
An antiglobulin test was performed in order to study the presence of H2 antigens on control and tyrosylated tumour cells. This was done using the isotopic antiglobulin technique described by Beverley and Simpson (1970) . An anti-CBA serum (a gift from Dr Peter Beverley) at 1/4 and 1/16 dilution was used, with a cell concentration of 20 million per ml. The results are expressed as absorption ratio; e.g. counts with anti-CBA serum: counts with normal serum at the same dilution.
DNFB skin painting
The clipped abdominal skin of mice was painted with 50 pl of a 0-5% solution (v/v) of DNFB in 50% olive oil-50% acetone 3 times at weekly intervals. One week later these mice were immunized with x-ray-killed control or DNFB-coated tumour cells.
DNP6 CGG immunization
Mice were immunized with 100 ,ug alumprecipitated DNP-chicken y-globulin (DNP6 CGG) using 2 x 109 pertussis organisms as adjuvant. Three weeks later they were immunized with x-ray-killed tumour cells. 
Viability of DNFB-coated spleen cells
In order to assess the effect of DNFB exposure on the viability of normal cells the following experiment was performed: a suspension of spleen cells free of contaminating RBC was prepared by NH4C1 lysis of RBC. The spleen cells were treated with DNFB as described earlier, and their ability to protect lethally irradiated mice (900 rad) from death was compared with that of normal spleen cells.
Viability of cells by trypan blue dye exclusion
Equal volumes of cells in Gey's solution and trypan blue (0.16% in saline) were mixed, and the proportion of cells excluding dye was determined microscopically.
RESULTS
Varying numbers of tumour cells from the third tumour passage were tested for their efficacy in establishing subcutaneous tumours. The number of viable tumour cells required to establish tumours in 5000 of recipient mice was between 103 and 104 cells (Table I) .
Exposure of tumour cells to varying concentrations of DNFB for 2 min at 30°C established that viability, as measured by trypan blue dye exclusion, was substantially diminished by concentrations of DNFB in excess of 0-25 pg/ml. Lesser concentrations of DNFB had little or no effect upon cell viability (Table II) . (Table IV) . The DNP sites/cell showed excellent correlation between the two parameters; with each tenfold dilution of DNFB during cell exposure, there was a 1 log decrement in the ability of the DNP-tumour cells to inhibit the ABC of the anti-DNP antiserum (Fig. 1) . In order to avoid saturation of the tumour cell membrane by DNP, and so render other cell surface antigens inactive or inaccessible. we chose 0-025 ,ug/ml as the concentration of DNFB during tumour cell dinitrophenylation for the following experiment. Control or DNP-tumour cells were exposed to 5000 rad in vitro to render them incapable of tumour formation. They were then injected i.p. into separate groups of control, DNFB skinpainted, or DNP6 CGG-immunized mice. Ten days later these mice, together with appropriate control unimmunized animals, were challenged with varying numbers of viable tumour cells and subsequently examined for tumour formation. Although earlier studies (Table VI; experiment I) has shown diminished tumour formation in control animals immunized with x-ray-killed tumour cells, in this experiment, immunization with neither x-ray-killed tumour cells nor x-ray-killed DNP-tumour cells resulted in significant protection against subsequent tumour formation when the animals were challenged with viable tumour cells, regardless of whether or not the animal had previously been exposed to the hapten (Table VI; Control mice
x-ray-killed tumour cells i.p. Experiment I skin-painted, or DNP6 CGG-immunized mice were challenged s.c. with graded numbers of viable, non-irradiated DNP tumour cells.* Prior host exposure to the hapten did not inhibit the formation of tumours by the challenge inoculum.
The effective tyrosylation of tumour cells was established by agglutination of the hapten-treated cells using anti poly-L-tyrosyl serum. Positive reaction between the cells exposed to 1 mg anhydride per 108 cells and the antiserum was observed at 1/128 dilution of the serum; cells treated with 10 mg anhydride per 108 cells were agglutinated by an antiserum dilution of 1/256.
The tyrosylation of tumour cells did not greatly diminish their viability, as measured by the trypan blue dye exclusion test (Table VII) . There was no significant change in the presence of H-2 antigens on dioxane-treated or tyro- (Table VIII) . The ability of tyrosylated tumour cells to induce subcutaneous tumours was reduced to approximately 1/100 of control values when 10 mg of tyrosine per 108 cells was used, and to 1/1000 of control values when absolute dioxane or 1 mg of tyrosine per 108 was used (Table IX) .
The effect of pre-immunization of mice with tyrosylated cells on subsequent tumour growth was investigated. Control, tyrosylated, and dioxane-treated tumour cells were exposed to 5000 rad in vitro and injected into different groups (Wolf et al., 1970) . Nevertheless, Martin et al. (1971) were able to detect slightly but significantly increased cell mediated cytotoxicity for native tumour cells in the spleens of animals immunized with DNPcoated cells. They did not investigate whether such in vitro evidence of immunity in DNP-tumour cell immunized animals correlated with an increased ability of such mice to reject tumours in vivo. Thus, although our results are at variance with theirs, the difference may simply reflect the discrepancy between the methods employed. Ultimately, however, the significance of any similar attempts to enhance the rejection of tumour cells by pre-immunization with hapten-coated cells will be best established by evidence of an in vivo expression of the immune state.
The fact that exposure of both tumour cells and normal spleen cells to DNFB yielded cells that were comparable both in the number of DNP molecules coupled, and in the subsequent viability of the DNP-coated cells, suggests that the effects of DNFB on tumour cells is not unique to special membrane adaptations related to their oncogenic properties. The methods of hapten attachment which we have described may be of value to other workers interested in pursuing this problem.
